severe cystic acne
Dermatology · 2018–2019
2decisions
1medicine
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| isotretinoin Treatment of severe cystic acne that is unresponsive to other therapy, including systemic antibiotics. | Nov 2019 | Recommended with restriction | none received |
| isotretinoin Treatment of severe cystic acne unresponsive to other therapy. The 5 mg strength provides dose optimisation for patients requiring lower doses than currently… | Nov 2018 | Recommended | none received |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.